FDA Inspection
Robert M. Pascuzzi, M.D.Robert M. Pascuzzi, M.D. – FDA Inspection, Nov 22, 2019
Record Details
This FDA Inspection record concerns Robert M. Pascuzzi, M.D., with an inspection on November 22, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Robert M. Pascuzzi, M.D.
- Inspection Date
- November 22, 2019
- Product Type
- Drugs
View Company Profile
ID · d50c25c6-741b-4967-bff1-266560cfabb2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1111300
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
5- 21 CFR 312.66Initial and continuing review
- 21 CFR 312.50Ensuring compliance with plan and protocol
- 21 CFR 312.59Records of unused drug disposition
- 21 CFR 312.66Unanticipated problems
- 21 CFR 50.20Consent not obtained, exceptions do not apply
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Robert M. Pascuzzi, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 27, 2023 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Robert M. Pascuzzi, M.D.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.